Updated September 2026Year preselected, month on topNext Vial review
The selector opens on the twelve-month card, and the month-to-month rate sits at the top of the same ladder.
The verdict
Next Vial prices compounded semaglutide at $199 for a month billed monthly, while the selector a buyer lands on has already chosen the twelve-month card at $99 a month, paid as $1,188 at once. Both numbers sit side by side on the product page, so the cost of declining a year's commitment is visible before a single medical question is asked.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide
- Form
- Injection
- States
- 49
- From
- From $199/mo
- Dose published
- No
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Named
- Availability
- 49 states
Next Vial is a telehealth marketplace that sells compounded semaglutide and compounded tirzepatide as weekly injections, alongside a catalog that runs from hormone therapy and peptides to hair loss, cold sores and smoking cessation. Its footer describes the company as a platform connecting patients with independently licensed providers, and says it neither dispenses medication nor provides medical care itself.
Who writes the prescription, and what do they see?
The FAQ names the clinician network plainly as MD Integrations, and it describes US-based physicians who review each questionnaire and reply within roughly a day of it being submitted. In certain states a video consultation or a live chat has to happen before a prescription is written. No individual physician is named anywhere on the site, and in most states the review rests on the written intake rather than a scheduled visit.
A buyer chooses the medication and the plan length first, answers the medical questions second, and then uploads a photo with an ID, which the FAQ puts down to state rules on identifying patients. The card is billed when the medication ships, and the FAQ says a patient is contacted before each refill is charged, the ordinary courtesy that keeps an automatic renewal from arriving unannounced on a statement.
What happens when the dose goes up?
Nothing on the product page prints a milligram beside any plan, so the dose a buyer starts on, and the doses that follow through the first four months of escalation, are left entirely to the provider. The page describes provider-personalized dosages at one all-in price without saying outright that a higher dose keeps the same figure. What the fifth month costs is a question to put to the provider before the first vial is opened.
What the price includes
The semaglutide ladder runs from $199 billed monthly to $507 for three months, $894 for six and $1,188 for twelve, which work out to $169, $149 and $99 a month. Tirzepatide has its own ladder in the same selector once it is chosen, and no monthly membership fee is charged on either. A separate banner lower on the same page advertises plans at a monthly figure that matches no card in the selector above it.
What it claims, and what it cites
Both lines are compounded, and the product page says so twice, adding that compounded medications are not FDA-approved and that the FDA has not verified their safety or effectiveness. The FAQ names the dispensing pharmacy as Manifest Pharmacy in Greer, South Carolina, with a phone number and weekday hours, which gives a buyer something concrete to check against a state pharmacy board before the first shipment arrives.
Where it holds up, and where it does not
- Strength: Clinician network named as MD Integrations
- Strength: Dispensing pharmacy named with its address
- Strength: Every rung printed with its upfront total
- Strength: No monthly membership fee
- Limitation: The default card is a twelve-month prepay
- Limitation: No milligram dose printed beside any plan
- Limitation: A banner figure matches no plan card
- Limitation: No individual physician is named
What the evidence says about this kind of treatment
The assessment above is about Next Vial. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A buyer who wants to see the full cost of each commitment length, and the name of the pharmacy, before answering a single medical question.
- Wrong for
- A buyer who wants a milligram schedule, and what each month of it will cost, laid out before signing up.
How Next Vial compares
| Seller | Who it suits | Go |
|---|---|---|
 Belle Health | Buyers ready to commit to a longer supply in exchange for a lower monthly rate | See Belle Health → |
 Liberty | A reader who wants to know what kind of facility made the vial, and will accept a mid-market rate to get that in writing. | See Liberty → |
 Science & Co | Buyers who want a flat rate across the dose ladder and will read the term in the FAQ | See Science & Co → |
More GLP-1 telehealth sellers reviews: Hello AlphaHenry MedsHeros HealthHersHimsHumeCare+
Sponsored alternative
Bodybuilding Health+
A reader unwilling to prepay a year before seeing how the drug goes
Check Bodybuilding Health+ availability →Frequently asked
- Is $99 a month what semaglutide costs?
- Only on the twelve-month plan, which is paid as $1,188 up front; the same selector prices a single month at $199, billed monthly, with no commitment beyond that month.
- Who writes the prescription?
- A physician from MD Integrations, the network that the Next Vial FAQ names, and in some states a video consultation or live chat has to take place before that prescription is written.
- Where does Next Vial ship?
- The FAQ lists forty-nine states by name, leaving Alaska off that list and making no mention of the District of Columbia, so a buyer in either place should ask before starting an intake.
- Is Next Vial legit?
- Next Vial is a GLP-1 telehealth sellers service. Its stated availability: 49 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Next Vial expensive compared with other GLP-1 telehealth sellers?
- Next Vial publishes a starting figure of $199/mo. Across the 368 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $449 with a median of $189, which puts Next Vial above the median. The other 20 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.